Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To further evaluate the serotonin (5‐HT) neurotoxic potential of substituted amphetamines, we used tritiated proline to examine anterograde transport along ascending axonal projections originating in the rostral raphe nuclei of animals treated 3 weeks previously with (±)fenfluramine (FEN, 10 mg/kg, every 2 h × 4 injections; i.p.) or (±)3,4‐methylenedioxymethamphetamine (MDMA, 20 mg/kg, twice daily for 4 days; s.c.). The documented 5‐HT neurotoxin, 5,7‐dihydroxytryptamine (5,7‐DHT, 75 μg; ICV; 30 min after pretreatment with pargyline, 50 mg/kg; i.p., and desipramine 25 mg/kg; i.p.), served as a positive control. Along with anterograde axonal transport, we measured two 5‐HT axonal markers, 5‐HT and 5‐hydroxyindoleacetic acid (5‐HIAA). Prior treatment with FEN or MDMA led to marked reductions in anterograde transport of labeled material to various forebrain regions known to receive 5‐HT innervation. These reductions were associated with lasting decrements in 5‐HT axonal markers. In general, decreases in axonal transport were less pronounced than those in 5‐HT and 5‐HIAA. However, identical changes were observed after 5,7‐DHT. These results further indicate that FEN and MDMA, like 5,7‐DHT, are 5‐HT neurotoxins. Synapse 40:113–121, 2001. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Mechan, A., Yuan, J., Hatzidimitriou, G., Irvine, R. J., McCann, U. D., & Ricaurte, G. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300808 · Cited by 67
“…studies demonstrating that MDMA, like 5,7-dihydroxytryptamine (5,7-DHT), can produce lasting reductions in anterograde axonal transport (Callahan et al, 2001), neurochemical and anatomic data have led a number of investigators to conclude that MDMA has the potential to damage brain…”
BackgroundSelf-citationEffects of stress and MDMA on hippocampal gene expression
Weber, G. F., Johnson, B. N., Yamamoto, B. K., & Gudelsky, G. A. (2014) · BioMed Research International · doi:10.1155/2014/141396 · Cited by 19
Metadata
- Authors
- Callahan, B. T., Cord, B. J., & Ricaurte, G. A.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2001-03-08
- Volume
- 40
- Issue
- 2
- Pages
- 113-121
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2090730172
- Cited by
- 60
- References
- 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. https://app.cochat.ai/papers/10.1002/syn.1032
- The paper
- Callahan, B. T., Cord, B. J., & Ricaurte, G. A. (2001). Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. Synapse. https://doi.org/10.1002/syn.1032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.